Prato, Italy

Raffaella Fabbri

This inventor holds 1 USPTO granted patent. Top assignee: Medi-Cult A/s. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raffaella Fabbri. Retrieved from https://idiyas.com/inventor/raffaella-fabbri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Raffaella Fabbri: Innovator in Oocyte Cryopreservation

Introduction: Raffaella Fabbri is a prominent inventor based in Prato, Italy. She has made significant contributions to the field of reproductive medicine, particularly in the cryopreservation of oocytes. Her innovative methods have the potential to enhance fertility treatments and improve outcomes for women undergoing assisted reproductive technologies.

Latest Patents: Raffaella Fabbri holds a patent for a method and solutions for cryopreserving oocytes, especially fresh human oocytes. The patent describes a process that utilizes freezing and thawing solutions, which include 1,2 propanediol (PROH) and sucrose at a concentration of at least 0.3M. In this method, oocytes are exposed for 13–15 minutes to a solution containing 1.5M PROH and 0.3M sucrose before the freezing process begins. This innovative approach aims to improve the viability of oocytes after thawing.

Career Highlights: Raffaella Fabbri has established herself as a key figure in the field of reproductive technology. Her work at Medi-Cult A/S has allowed her to focus on developing advanced solutions for fertility preservation. With her expertise, she has contributed to the advancement of techniques that support women's reproductive health.

Collaborations:

Conclusion: Raffaella Fabbri's contributions to the field of cryopreservation represent a significant advancement in reproductive medicine. Her innovative methods have the potential to improve fertility treatments and provide hope to many women seeking to preserve their reproductive options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…